Astellas’ Izervay Joins Geographic Atrophy Market, Intensifying Competition

 
• By Jessica Merrill
  
competitive edge
Astellas hopes to have a competitive edge over Apellis in geographic atrophy • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Sensory

More from Therapeutic Category